Suppr超能文献

Erythropoietin and Parkinson's disease: Suggested mechanisms and therapeutic implications.

作者信息

Genc Kursad

出版信息

Med Hypotheses. 2008;70(1):211-2. doi: 10.1016/j.mehy.2007.04.010. Epub 2007 Jun 5.

Abstract
摘要

相似文献

1
Erythropoietin and Parkinson's disease: Suggested mechanisms and therapeutic implications.
Med Hypotheses. 2008;70(1):211-2. doi: 10.1016/j.mehy.2007.04.010. Epub 2007 Jun 5.
3
Neuroprotection in Parkinson's disease: an elusive goal.
Semin Neurol. 2007 Apr;27(2):106-12. doi: 10.1055/s-2007-971168.
4
Why hasn't neuroprotection worked in Parkinson's disease?
Nat Clin Pract Neurol. 2007 May;3(5):240-1. doi: 10.1038/ncpneuro0491.
5
Rationale for the use of dopamine agonists as neuroprotective agents in Parkinson's disease.
Ann Neurol. 2003;53 Suppl 3:S149-57; discussion S157-9. doi: 10.1002/ana.10514.
6
Rasagiline -- is there a place for this drug in managing Parkinson's disease?
Int J Clin Pract. 2006 Feb;60(2):132-3. doi: 10.1111/j.1742-1241.2006.00843d.x.
7
New hope for mechanism-based treatment of Parkinson's disease.
Drug Discov Today. 2005 Jan 15;10(2):80-1. doi: 10.1016/S1359-6446(04)03340-9.
9
Protective effect of bromocriptine against BH4-induced Cath.a cell death involving up-regulation of antioxidant enzymes.
Neurosci Lett. 2009 Feb 27;451(3):185-9. doi: 10.1016/j.neulet.2008.12.056. Epub 2009 Jan 6.
10
Rasagiline as a therapy for Parkinson's disease (PD).
Am J Geriatr Pharmacother. 2007 Jun;5(2):174-5; author reply 175-6. doi: 10.1016/j.amjopharm.2007.06.002.

引用本文的文献

1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验